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Abstract
Purpose: We intended to study the impact of patient positioning on the dosedistribution within target volume and organs at risk in patients with parotidmalignancies treated with 3D conformal radiotherapy (3D-CRT) with photon wedgepair (WP) or intensity modulated radiotherapy (IMRT). Methods: Three patients witha non-Hodgkin’s lymphoma of the right parotid gland were consecutively immobilizedusing thermoplastic cast in 2 positions: supine with head in neutral position (HN) andwith head turned 90° to the left side (HT). Images for treatment planning purposewere acquired in both positions. For both positions, photon WP plans and 5 field IMRTplans were generated, after contouring clinical target volume (CTV), planning targetvolume (PTV= CTV + 5 mm margin) and organs at risk (OAR). All plans were evaluatedfor target coverage and dose to OARs. Results: Both CTV and PTV were apparentlylarger in HN compared with HT (31.76±8.89 cc, 30.31±7.83 cc and 62.49±19.01 cc,58.89±15.33 cc) respectively. The CI value for PTV was slightly better for HTcompared to HN position in both the WP and IMRT plans. The homogeneity wascomparable in both the head positions in case of WP plan. The mean HI of PTV wasincreased in case of IMRT plan at HT versus HN position (1.108 vs. 1.097). A change inhead position from HN to HT with wedge pair plan resulted in a reduction ofbrainstem Dmax and Dmean. Lesser dose was observed in HN position for contralateralparotid. A difference of 0.9 Gy in the average Dmax to spinal cord was seen. The valuesof Dmean to mandible, oral cavity, ipsilateral and contralateral cochlea were higher inthe HT position. A change in head position from HN to HT with IMRT plan resulted in adose reduction in average Dmax to brainstem. The spinal cord Dmax increased at the HTposition by 1.2 Gy. The dose to contralateral parotid and cochlea was comparable inboth the positions. However, the Dmean to oral cavity was reduced at HT position.Whereas for IMRT versus wedge pair plan at head neutral position average Dmean tothe contralateral parotid was reduced with the IMRT plan. A considerable reduction inDmax to spinal cord and Dmean to ipsilateral cochlea was observed. A slight increase inaverage Dmax to brainstem and was observed with the IMRT plan. The doses to theremaining OARs were lesser in case of IMRT plan. For IMRT versus wedge pair plan athead tilt position slight increase in average Dmax to brainstem was observed in case ofIMRT plan. A considerable reduction in Dmax to spinal cord and Dmean to ipsilateralcochlea was observed. The doses to the remaining OARs were reduced with IMRTplan. Conclusion: Change in head position from neutral to 90° contralateral tilt forwedge pair plan in parotid tumor may considerably reduce dose to the brainstem andspinal cord with a modest increase in dose to mandible, oral cavity, contralateralparotid, and bilateral cochlea. The alteration in head position has minimal impact onIMRT planning.
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1. IntroductionNewer methods and techniques continue to be exploredin radiotherapy practice for achieving the goal ofmaximum tumor dose with sparing of normal structures.The patient position and immobilization plays apertinent role in external beam radiotherapy planning.Many authors have studied the influence of treatmentposition on radiotherapy dose distribution. Wilder et al.1compared the prostate intrafraction motion in proneand supine position author concluded that prone andsupine positions resulted in a similar magnitude ofanteroposterior (AP) and superoinferior intrafractionprostate motion (2 mm). Krengli et al.2 analyzed thedosimetric parameters of patients receiving adjuvantbreast radiotherapy (RT) in prone versus supineposition and found that prone position is a favorablealternative for irradiation of mammary gland in patientswith pendulous breasts. Sharma et al.3 studied theimpact of patient position (supine and prone) onpatients of brainstem glioma and concluded that supineand prone positions resulted in almost similar dosedistribution. Bakkal et al.4 evaluated the effect ofradiotherapy on testicles with different treatmentpositions and plans for rectal cancer patients andconcluded that supine 4-fields (S4f) external beamradiotherapy for rectal carcinoma allows bettertesticular dose than prone 3-fields (p3f) and prone4-fields (p4f). Drzymala et al.5 also studied the volume ofbowel and dose received in the prone and supinepositions in patients undergoing pre-operative rectalcancer chemoradiation, results showed that volume ofbowel irradiated is not significantly higher in supineposition. The supine with head neutral (HN) treatmentposition is employed for planning radiotherapy in headand neck cancer patients. A pair of angled wedge photonbeam is the most common radiation planning techniquefor parotid tumors.6, 7 Since patients with parotid tumorsrequire unilateral irradiation, a change in position fromHN to head tilt (HT) may alter the dose distribution. Thepurpose of this study was to evaluate the influence ofhead positioning on dose distribution within the targetvolume and organs at risk (OARs) in patients withparotid tumor. The plans with 3-D conformal radiationtherapy (3-DCRT) and intensity modulated radiationtherapy (IMRT) were compared alongside the twodifferent head positions.
2. Methods and MaterialsThree patients with right-sided parotid tumor weretreated with radiotherapy. The patients wereimmobilized using a thermoplastic mould in twopositions: supine with head in neutral (HN) and tilted tothe contralateral side at 90 degree (HT). Computedtomography (CT) scan of the head and neck region wasperformed at 3 mm slice thickness in both the headpositions. The CT images were transferred to theEclipseTM (Varian medical system, Palo Alto, CA, Heliosversion 6.5) treatment planning system (TPS) via
DICOM. The clinical target volume (CTV), planning targetvolume (PTV), and OARs i.e., contralateral parotid,brainstem, spinal cord, oral cavity, cochlea, andmandible were contoured in both scans for all patients.PTV was generated from CTV with a 5 mm margin. PTVwas intersected with body contour by 2 mm margin.Two plans with 3-DCRT and IMRT were generated foreach of the six CT datasets. The plan with 3-DCRT wasgenerated with a photon wedge pair (WP). Five fieldswere employed for generating an IMRT plan. The planswere made for Varian CL2300C/D linear accelerator(Varian Medical Systems, Palo Alto, CA, USA) using 6 MVX-rays. The linear accelerator has 40 pairs of multi-leafcollimator (MLC) with a leaf thickness of 1 cm atisocenter.
2.1 Dose prescriptionA dose of 60 Gy in 30 fractions was prescribed to thePTV. All plans were prescribed at 95% isodose line.
2.2 Wedge pair planThe plan was made with two oblique fields using 45degree wedge. The beam’s-eye-view (BEV) option of theTPS was employed to select the appropriate gantry angleto allow coverage of the PTV while minimizing the doseto OARs. The MLC was geometrically shaped around thePTV with a 7 mm margin for penumbra. A 0.5 cm boluswas added for achieving a dose build-up at surface.
2.3 IMRT planThe plan was made using five coplanar beams. Thegantry angles were 00, 500, 1500, 2000, 3000and 00, 720,2100, 2700, 3080 for the respective HN and HT positionin case of right-sided parotid tumor. An ipsilateral beamarrangement was employed to provide an optimal dosedistribution with maximum sparing of ipsilateral andcontralateral OARs. Bolus was not applied in the IMRToptimization. The following dose constraints wereimposed for the inverse-planning optimization: atleast95% of PTV volume to receive 95% of prescription dose,brainstem maximum dose (Dmax) ≤54 Gy, spinal cordDmax ≤45 Gy, cochlea mean dose (Dmean) ≤45 Gy,contralateral parotid gland Dmean ≤26 Gy, mandible Dmax≤70 Gy, and oral cavity Dmean ≤45 Gy.
2.4 Plan evaluationAll plans were analyzed using DVH. The target coveragewas analyzed in terms of minimum, maximum, andmean dose. Coverage index (CI) and heterogeneity index(HI) for PTV were calculated.8CI = TVRI/TVwhere, TVRI = target volume covered by the referenceisodose; TV =target volumeThis index ranges from 0 to 1. The range of CI shows theamount of conformation because a value of 1 is rarelyachieved. The volume of adjacent healthy tissues is nottaken into account in this index.
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HI= D5%/ D95%where, D5% = dose delivered to 5% of PTV volume; D95%= dose delivered to 95% of PTV volumeIt is evident that if the value of heterogeneity index iscloser to 1, the better will be the dose homogeneity forPTV.The maximum and mean dose to brain-stem,contra-lateral parotid gland, mandible, oral cavity,bilateral cochlea was noted. Maximum dose to spinalcord was noted.
3. ResultsThe dose distribution for the wedge pair and IMRT planin neutral and tilted head position is demonstrated in
Figure 1.
Figure 1: The field setup and isodose line with wedge pair and IMRT plan at neutral (a, b) and tilted (c, d) head position onaxial CT slice for a representative patient
Table 1: The target volume for the respective head position.
Head neutral Head tiltCTV Volume (cc) PTV volume (cc) CTV volume (cc) PTV volume (cc)Patient 1 24.30 49.50 23.80 48.50Patient 2 41.60 84.30 39.00 76.50Patient 3 29.38 53.66 28.12 51.68Abbreviations: CTV = Clinical target volume; PTV = Planning target volume
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Table 2: The target volume dose parameters and indices for the respective head position.
Head neutral Head tiltIMRT WP IMRT WPPTV Dmax (Gy) 66.23±0.45 67.42±0.51 66.31±0.55 67.04±0.85PTV Dmean (Gy) 63.01±0.81 64.03±0.51 63.45±0.16 63.99±0.68PTV Coverage index (CI) 0.927±0.03 0.971±0.01 0.931±0.03 0.978±0.03PTV Heterogeneity index (HI) 1.097±0.03 1.093±0.01 1.108±0.03 1.082±0.02Abbreviations: IMRT = Intensity modulated radiation therapy; WP = Wedge pair; PTV = Planning target volume
Table 3: The maximum and mean doses to organs at risk for the respective head position.
Head neutral Head tiltIMRT WP IMRT WPBrainstemDmax (Gy) 22.99±7.31 20.71±11.03 19.81±5.70 17.38±8.40Dmean (Gy) 6.83±4.44 7.29±2.78 7.67±3.50 5.40±4.70Contralateralparotid Dmax (Gy) 6.83±5.65 8.78±9.49 6.62±4.37 14.9±12.14Dmean (Gy) 1.17±0.49 4.54±5.52 2.94±2.65 8.07±6.50Spinal cordDmax (Gy) 19.75±15.85 26.72±13.57 20.98±11.29 25.83±2.98MandibleDmax (Gy) 64.29±0.31 65.85±1.21 64.71±0.27 65.69±0.42Dmean (Gy) 24.04±1.76 23.76±3.21 22.51±2.97 25.44±11.01Oral cavityDmax (Gy) 33.88±2.92 37.89±21.69 33.87±22.81 39.85±21.69Dmean (Gy) 20.23±6.74 20.98±2.87 16.48±7.29 23.74±12.19Ipsilateral cochleaDmax 18.57±11.60 26.25±7.14 19.28±10.73 34.71±12.12Dmean (Gy) 6.06±3.95 20.96±9.26 13.31±6.81 23.59±12.70Contralateralcochlea Dmax (Gy) 2.65±1.01 1.97±0.86 4.56±3.81 3.50±2.71Dmean (Gy) 1.57±0.46 1.60±0.65 3.74±3.40 1.94±0.81Abbreviations: IMRT = Intensity modulated radiation therapy; WP = Wedge pairThe volume of CTV and PTV for the HN and HT positionis listed in Table 1.The average volume of CTV and PTV in HN position was31.76±8.89 cc and 62.49±19.01 cc, respectively. Whilethe respective values in HT position were 30.31±7.83 ccand 58.89±15.33 cc. The measured target volume wasapparently larger in HN as compared to the HT position.The PTV dose parameters and indices are listed in Table
2.The CI value for PTV was slightly better for HTcompared to HN position in both the WP and IMRTplans. The dose distribution in IMRT more closelymatched the shape of PTV as compared with the WPplan. Since bolus was not applied for optimization inIMRT, there was under-dosing of PTV in the build-upregion. This resulted in lower mean CI value with IMRTin contrast to WP plan.The homogeneity was comparable in both the headpositions in case of WP plan. The mean HI of PTV was
increased in case of IMRT plan at HT versus HN position(1.108 vs. 1.097). The best homogeneity was observedwith WP plan at HT position (mean HI=1.082).The doses to OARs with the plans at respective headposition are listed in Table 3.
3.1 Head neutral versus tilt position with wedge
pair planA change in head position from HN to HT resulted in areduction of brainstem Dmax and Dmean. A major variationin the Dmax and Dmean to the contralateral parotid wasobserved with lesser doses at the HN position (averageDmean 4.54 Gy vs. 8.07 Gy). A difference of 0.9 Gy in theaverage Dmax to spinal cord was seen. The values of Dmeanto mandible, oral cavity, ipsilateral and contralateralcochlea were higher in the HT position.
3.2 Head neutral versus tilt position with IMRT
planA change in head position from HN to HT resulted in adose reduction in average Dmax to brainstem (22.99 Gyvs. 19.81 Gy). The spinal cord Dmax increased at the HT
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position by 1.2 Gy. The dose to contralateral parotid andcochlea was comparable in both the positions. However,the Dmean to oral cavity was reduced at HT position.
3.3 IMRT versus wedge pair plan at head neutral
positionThe average Dmean to the contralateral parotid wasreduced with the IMRT plan (1.17 Gy vs. 4.54 Gy). Aconsiderable reduction in Dmax to spinal cord and Dmeanto ipsilateral cochlea was observed. A slight increase inaverage Dmax to brainstem and was observed with theIMRT plan (22.99 Gy vs. 20.71 Gy). The doses to theremaining OARs were lesser in case of IMRT plan.
3.4 IMRT versus wedge pair plan at head tilt
positionA slight increase in average Dmax to brainstem wasobserved in case of IMRT plan (19.81 Gy vs. 17.38 Gy). Aconsiderable reduction in Dmax to spinal cord and Dmeanto ipsilateral cochlea was observed. The doses to theremaining OARs were reduced with IMRT plan.
4. DiscussionVarious planning techniques have been described forparotid gland tumour. The ipsilateral WP, WP withlateral portal (3-fields), and the mixed electron-photonbeam were considered the optimal techniques in a studyby Yaparpalvi et al.9 The WP planning has beenconventionally described in supine with HN position.The present study elaborated on dosimetry in tiltedhead as compared with the neutral position. The targetcoverage and sparing of normal structures wereacceptable with the plans at both head positions.However, an increase in dose to mandible and oralcavity was observed with WP plan at HT position, sincethe beam entry and exit was unavoidable through thesestructures in this position. Similarly, IMRT plan in bothhead positions demonstrated almost same results withrespect to the doses to target and OARs.Nutting et al.10 compared the conventional radiotherapy,3-DCRT, and IMRT for patients with parotid glandtumors. A reduction in the radiation dose to criticalnormal tissues was demonstrated with 3-DCRTcompared with conventional radiotherapy. A furtherreduction in the dose to the cochlea and oral cavity wasobserved with IMRT. With nine and seven fields, thedose to the contra-lateral parotid gland was increased,but this was avoided by optimization of the beamdirections. The benefits of IMRT were maintained withthree or four fields when the beam angles wereoptimized. Bragg et al.11 compared IMRT with 3-DCRTplans for the treatment of tumors of parotid gland. AnIMRT class solution of five fields at 150, 550, 1250, 1650,and 2700 was proposed which resulted in improvedtarget dose distribution and sparing of critical structureswith an efficient treatment delivery. IMRT reduced themean dose to the contralateral parotid gland and the
maximum doses to the brain and the spinal cord, butincreased the ipsilateral lens dose in some cases. A study12 compared 3D-CRT and IMRT with respect to hearingloss. The mean volume of the inner ear receiving a dosehigher than 50 Gy decreased from 14.7% to 1.4%.Likewise, the current study showed a superior sparingof relatively all OARs with IMRT. A considerablereduction in dose to ipsilateral ear was observed whichwas not achievable with a WP plan (average Dmean 6.06Gy vs 20.96 Gy in HN position).
5. ConclusionA change in head position from neutral to 90°contralateral tilt for wedge pair plan in parotid tumormay considerably reduce dose to the brainstem andspinal cord with a modest increase in dose to mandible,oral cavity, contralateral parotid, and bilateral cochlea.The alteration in head position has minimal impact onIMRT planning. Head position and treatment techniquemay be selected according to the clinical requirement onan individual case basis.
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